Rifabutin Versus Rifampicin for Treatment of Staphylococcal PJI Treated With DAIR — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Rifabutin Versus Rifampicin for Treatment of Staphylococcal PJI Treated With DAIR — Stella

Recruiting

Back to Prosthetic Infection trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(30 sites)

France

CHU Amiens Picardie, Amiens

CHU Angers, Angers

CHU Besançon, Besançon

CH de Béthune, Béthune

CHU Bordeaux, Bordeaux

Key details

Phase

Large-scale testing

Sponsor

Tourcoing Hospital

Enrollment target

~436 participants

Started

November 2021

Primary completion

November 2026

Age range

18 Years and older

Last updated May 2022

Interested in joining?

View full record on ClinicalTrials.gov

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.